Robert Newton1,2, Nazzarena Labo3, Katie Wakeham1,4, Vickie Marshall3, Romin Roshan3, Angela Nalwoga1,5, Ismail Sebina6, Lawrence Muhangi1,5, Emily L Webb5, Wendell Miley3, Rosemary Rochford7, Alison M Elliott1,5, Denise Whitby3. 1. Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda. 2. University of York, York. 3. Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Inc.-Frederick National Laboratory for Cancer Research, Maryland. 4. Sussex Cancer Center, Brighton and Sussex University Hospitals, National Health Service Trust, Sussex. 5. London School of Hygiene and Tropical Medicine, London, United Kingdom. 6. Department of Immunology, University of Washington, Seattle. 7. Department of Immunology and Microbiology, University of Colorado, Denver.
Abstract
Background: Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) are transmitted via saliva, but factors associated with salivary shedding are unknown. Methods: We measured the DNA load of both viruses in saliva specimens collected from approximately 500 Ugandan mothers and their 6-year-old children, testing all participants for EBV and KSHV-seropositive individuals for KSHV. Results: EBV and KSHV were shed by 72% and 22% of mothers, respectively, and by 85% and 40% of children, respectively; boys were more likely than girls to shed KSHV (48% vs 30%) but were equally likely to shed EBV. Children shed more KSHV and EBV than mothers, but salivary loads of EBV and KSHV were similar. KSHV shedding increased with increasing anti-KSHV (K8.1) antibodies in mothers and with decreasing antimalarial antibodies both in mothers and children. Among mothers, 40% of KSHV shedders also shed EBV, compared with 75% of KSHV nonshedders; among children, EBV was shed by 65% and 83%, respectively. Conclusions: In summary, in this population, individuals were more likely to shed EBV than KSHV in saliva. We identified several factors, including child's sex, that influence KSHV shedding, and we detected an inverse relationship between EBV and KSHV shedding, suggesting a direct or indirect interaction between the two viruses.
Background: Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) are transmitted via saliva, but factors associated with salivary shedding are unknown. Methods: We measured the DNA load of both viruses in saliva specimens collected from approximately 500 Ugandan mothers and their 6-year-old children, testing all participants for EBV and KSHV-seropositive individuals for KSHV. Results: EBV and KSHV were shed by 72% and 22% of mothers, respectively, and by 85% and 40% of children, respectively; boys were more likely than girls to shed KSHV (48% vs 30%) but were equally likely to shed EBV. Children shed more KSHV and EBV than mothers, but salivary loads of EBV and KSHV were similar. KSHV shedding increased with increasing anti-KSHV (K8.1) antibodies in mothers and with decreasing antimalarial antibodies both in mothers and children. Among mothers, 40% of KSHV shedders also shed EBV, compared with 75% of KSHV nonshedders; among children, EBV was shed by 65% and 83%, respectively. Conclusions: In summary, in this population, individuals were more likely to shed EBV than KSHV in saliva. We identified several factors, including child's sex, that influence KSHV shedding, and we detected an inverse relationship between EBV and KSHV shedding, suggesting a direct or indirect interaction between the two viruses.
Authors: Teun Bousema; Randa M Youssef; Jackie Cook; Jonathan Cox; Victor A Alegana; Jamal Amran; Abdisalan M Noor; Robert W Snow; Chris Drakeley Journal: Emerg Infect Dis Date: 2010-03 Impact factor: 6.883
Authors: Sam Mbulaiteye; Vickie Marshall; Rachel K Bagni; Cheng-Dian Wang; Georgina Mbisa; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Eric A Engels; Edward Katongole-Mbidde; Robert J Biggar; Denise Whitby Journal: J Infect Dis Date: 2006-03-17 Impact factor: 5.226
Authors: Alison M Elliott; Denise Whitby; Robert Newton; Katie Wakeham; Emily L Webb; Ismail Sebina; Lawrence Muhangi; Wendell Miley; W Thomas Johnson; Juliet Ndibazza Journal: Infect Agent Cancer Date: 2011-09-30 Impact factor: 2.965
Authors: Alison M Elliott; Proscovia B Namujju; Patrice A Mawa; Maria A Quigley; Margaret Nampijja; Peter M Nkurunziza; John T Belisle; Moses Muwanga; James A G Whitworth Journal: BMC Infect Dis Date: 2005-12-21 Impact factor: 3.090
Authors: Katie Wakeham; W Thomas Johnston; Angela Nalwoga; Emily L Webb; Billy N Mayanja; Wendell Miley; Alison M Elliott; Denise Whitby; Robert Newton Journal: Int J Cancer Date: 2014-11-28 Impact factor: 7.396
Authors: Robert Newton; Denise Whitby; Inês Barroso; Neneh Sallah; Wendell Miley; Nazzarena Labo; Tommy Carstensen; Segun Fatumo; Deepti Gurdasani; Martin O Pollard; Alexander T Dilthey; Alexander J Mentzer; Vickie Marshall; Elena M Cornejo Castro; Cristina Pomilla; Elizabeth H Young; Gershim Asiki; Martin L Hibberd; Manjinder Sandhu; Paul Kellam Journal: Nat Commun Date: 2020-07-31 Impact factor: 14.919